Frédéric Garban

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau et al. · Blood · 2007 · 905 citations · Full text

Medicine, Genetics, Hematology +15

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

Frédéric Garban, Michel Attal, Mauricette Michallet et al. · Blood · 2006 · 370 citations · Full text

Medicine, Hematology, Oncology +16

Achievement of at Least Very Good Partial Response Is a Simple and Robust Prognostic Factor in Patients With Multiple Myeloma Treated With High-Dose Therapy: Long-Term Analysis of the IFM 99-02 and 99-04 Trials

Jean‐Luc Harousseau, Hervé Avet‐Loiseau, Michel Attal et al. · Journal of Clinical Oncology · 2009 · 165 citations · Full text

Medicine, Oncology, Cell Therapy +15

Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation

Sandrine Venier, Nathan Vaxelaire, Peggy Jacon et al. · EP Europace · 2023 · 160 citations · Full text

Medicine, Cardiology, Nephrology +11

Detection of Circulating <i>Aspergillus fumigatus</i> Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis

Claudine Pinel, Hélène Fricker‐Hidalgo, B. Lebeau et al. · Journal of Clinical Microbiology · 2003 · 146 citations

Life Sciences, Infectious Diseases, Microbiology +15